Linical Co., Ltd. (TYO:2183)
Japan · Delayed Price · Currency is JPY 204.00
-5.00 (-2.39%)
Jun 24, 2026, 3:30 PM JST
Linical Market Cap
Linical has a market cap or net worth of 4.72 billion as of June 24, 2026. Its market cap has decreased by -31.48% in one year.
Market Cap
4.72B
Enterprise Value
1.77B
Revenue
8.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
204.00
Market Cap Chart
Since October 27, 2008, Linical's market cap has decreased from 9.24B to 4.72B, a decrease of -48.91%. That is a compound annual growth rate of -3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 4.72B | -28.67% |
| Dec 30, 2025 | 6.62B | -15.80% |
| Dec 30, 2024 | 7.86B | -34.34% |
| Dec 29, 2023 | 11.97B | -23.19% |
| Dec 30, 2022 | 15.58B | -11.31% |
| Dec 30, 2021 | 17.57B | 10.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 6.49B |
| Soiken Holdings | 6.30B |
| BrightPath Biotherapeutics | 6.25B |
| CellSource | 6.23B |
| Noile-Immune Biotech | 5.25B |
| Kohjin Bio | 5.03B |
| Chiome Bioscience | 5.00B |
| PRISM BioLab Co.,LTD | 4.81B |